Monash, BiVACOR-led consortium to develop and commercialise world-first durable total artificial heart

The BiVACOR Total Artificial Heart shown in the chest cavity (left) and transparent image demonstrating the capacity to support the whole heart (right).

A national consortium of universities, hospitals and industry, led by Monash University and BiVACOR, have received $1 million from the Medical Research Future Fund to develop and commercialise a world-first durable Total Artificial Heart.

Heart failure is an epidemic that impacts more than 300,000 Australians. There is a clear gap in the market for patient-friendly devices to provide a solution to this chronic health challenge.

The research team seeks to take this new artificial heart technology to market within the six-year duration of MRFF Frontiers program. See full story